बोस्निया और हर्ज़ेगोविना - क्रोएशियाई - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

novartis ba d.o.o. - trametinib - filmom obložena tableta - 0,5 mg/1 tableta - 1 filmom obložena tableta sadrži: 0,5 mg trametiniba (u obliku trametinib dimetil sulfoksida)

बोस्निया और हर्ज़ेगोविना - क्रोएशियाई - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

novartis ba d.o.o. - trametinib - filmom obložena tableta - 2 mg/1 tableta - 1 filmom obložena tableta sadrži: 2 mg trametiniba (u obliku trametinib dimetil sulfoksida)

यूरोपीय संघ - क्रोएशियाई - EMA (European Medicines Agency)

ceva santé animale - spironolakton - diuretici - psi - za upotrebu u kombinaciji sa standardnom terapijom (uključujući i diuretsku podršku, gdje je to potrebno) za liječenje kongestivnog zatajenja srca uzrokovanog ventilskom regurgitacijom kod pasa.

यूरोपीय संघ - क्रोएशियाई - EMA (European Medicines Agency)

ceva santé animale - benazepril hydrochloride, spironolactone - kardiovaskularnog sustava - psi - za liječenje kongestivnog zatajenja srca uzrokovanog kroničnom degenerativnom bolesti pilula kod pasa (s prikladnom diuretskom podrškom).

क्रोएशिया - क्रोएशियाई - HALMED (Agencija za lijekove i medicinske proizvode)

mibe pharmaceuticals d.o.o., zavrtnica 17, zagreb, hrvatska - fluorouracil salicilatna kiselina - otopina za kožu - 5 mg/g + 100 mg/g - urbroj: 1 g otopine sadrži 5 mg fluorouracila i 100 mg salicilatne kiseline

यूरोपीय संघ - क्रोएशियाई - EMA (European Medicines Agency)

pierre fabre medicament - tabelecleucel - lymphoproliferative disorders - ebvallo is indicated as monotherapy for treatment of adult and paediatric patients 2 years of age and older with relapsed or refractory epstein-barr virus positive post-transplant lymphoproliferative disease (ebv+ ptld) who have received at least one prior therapy. for solid organ transplant patients, prior therapy includes chemotherapy unless chemotherapy is inappropriate.

यूरोपीय संघ - क्रोएशियाई - EMA (European Medicines Agency)

ab science s.a. - masitinib mesilate - antineoplastična sredstva - psi - liječenje ne-resektabilnih pasa mast-stanica tumora (stupanj 2 ili 3) s potvrđenim mutiranim c-kit tirozin-kinaznim receptorom.

यूरोपीय संघ - क्रोएशियाई - EMA (European Medicines Agency)

ceva santé animale - pyriproxyfen, dinotefuran - Противопаразитарные lijekovi, insekticidi i repelenti druge ectoparasiticides za vanjsku primjenu, pyriproxyfen, kombinacije - mačke - prevencija i liječenje invazija buha (ctenocephalides feliz) na mačkama. jedna aplikacija sprečava buha provalama u roku od jednog mjeseca. ona također sprečava razmnožavanje buha, sprječava pojavu buha u okruženju mačka na 3 mjeseca.

यूरोपीय संघ - क्रोएशियाई - EMA (European Medicines Agency)

novartis europharm limited - trametinib - melanoma - antineoplastična sredstva - melanomatrametinib as monotherapy or in combination with dabrafenib is indicated for the treatment of adult patients with unresectable or metastatic melanoma with a braf v600 mutation (see sections 4. 4 i 5. trametinib monotherapy has not demonstrated clinical activity in patients who have progressed on a prior braf inhibitor therapy (see section 5. adjuvant treatment of melanomatrametinib in combination with dabrafenib is indicated for the adjuvant treatment of adult patients with stage iii melanoma with a braf v600 mutation, following complete resection. Немелкоклеточный rak pluća (НМРЛ)trametinib u kombinaciji s dabrafenib indiciran za liječenje odraslih bolesnika s preliminarnim non-mali raka pluća stanice s Браф mutacija v600 daleko .

यूरोपीय संघ - क्रोएशियाई - EMA (European Medicines Agency)

novartis europharm limited - tisagenlecleucel - precursor b-cell lymphoblastic leukemia-lymphoma; lymphoma, large b-cell, diffuse - drugi antineoplastični agensi - kymriah is indicated for the treatment of:• paediatric and young adult patients up to and including 25 years of age with b cell acute lymphoblastic leukaemia (all) that is refractory, in relapse post transplant or in second or later relapse. • adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl) after two or more lines of systemic therapy. • adult patients with relapsed or refractory follicular lymphoma (fl) after two or more lines of systemic therapy.